Kidney Research and Clinical Practice

Kidney Health Plan 2033 in Korea: bridging the gap between the present and the future: Do Hyoung Kim, Young Youl Hyun, Jin Joo Cha et al.; Kidney Res Clin Pract. 2024;43(1):8-19. Published online January 31, 2024; DOI: https://doi.org/10.23876/j.krcp.23.232
Web of Science 3 Cited By 3; Full text PubReader ePub PDF

Pan-Nox inhibitor treatment improves renal function in aging murine diabetic kidneys: Jeong Hoon Park, Sung Gi Yoon, Jung Yeon Ghee et al.; Kidney Res Clin Pract. 2024;43(6):763-773. Published online August 10, 2023; DOI: https://doi.org/10.23876/j.krcp.23.004
Cited By 1; Full text PubReader ePub PDF

A multicenter, randomized, open-label, comparative, phase IV study to evaluate the efficacy and safety of combined treatment with mycophenolate mofetil and corticosteroids in advanced immunoglobulin A nephropathy: Sang Youb Han, Chan-Young Jung, Sang Ho Lee et al.; Kidney Res Clin Pract. 2022;41(4):452-461. Published online May 4, 2022; DOI: https://doi.org/10.23876/j.krcp.21.146
Web of Science 6 Cited By 5; Full text PubReader ePub PDF Supplementary Material

Serum interferon-γ and urinary monocyte chemoattractant peptide-1 are important factors in the pathogenesis of immunoglobulin A nephropathy: Sang Youb Han, Kyung Hwan Jeong, Chun-Gyoo Ihm, Young Sun Kang, Dae Ryong Cha; Kidney Res Clin Pract. 2021;40(1):69-76. Published online March 12, 2021; DOI: https://doi.org/10.23876/j.krcp.20.157
Web of Science 5 Cited By 6; Full text PubReader ePub PDF Supplementary Material

Physicians’ perceptions of asymptomatic hyperuricemia in patients with chronic kidney disease: A questionnaire survey: Ran-hui Cha, Su Hyun Kim, Eun Hui Bae et al.; Kidney Res Clin Pract. 2019;38(3):373-381. Published online September 30, 2019; DOI: https://doi.org/10.23876/j.krcp.19.007
Web of Science 4 Cited By 4; Full text PubReader PDF Supplementary Material

Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea [Volume 36, Issue 1, March 2017, Pag: Ran-hui Cha, Shin Wook Kang, Cheol Whee Park et al.; Kidney Res Clin Pract. 2018;37(1):98-99. Published online March 31, 2018; DOI: https://doi.org/10.23876/j.krcp.2018.37.1.98; Full text PubReader PDF

Renoprotective effects of febuxostat compared with allopurinol in patients with hyperuricemia: A systematic review and meta-analysis: Sollip Kim, Hyun-Jung Kim, Hyeong-Sik Ahn et al.; Kidney Res Clin Pract. 2017;36(3):274-281. Published online September 30, 2017; DOI: https://doi.org/10.23876/j.krcp.2017.36.3.274
Web of Science 40 Cited By 38; Full text PubReader PDF Supplementary Material

Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea: Ran-hui Cha, Shin Wook Kang, Cheol Whee Park et al.; Kidney Res Clin Pract. 2017;36(1):68-78. Published online March 31, 2017; DOI: https://doi.org/10.23876/j.krcp.2017.36.1.68
Web of Science 34 Cited By 33; Full text PubReader PDF Supplementary Material

Plasma leptin concentrations are greater in type II diabetic patients and stimulate monocyte chemotactic peptide-1 synthesis via the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway: Jin Joo Cha, Young Youl Hyun, Yi Hwa Jee et al.; Kidney Res Clin Pract. 2012;31(3):177-185. Published online June 26, 2012; DOI: https://doi.org/10.1016/j.krcp.2012.06.004
Cited By 6; Full text PubReader PDF

3,476	Unveiling the enigma of acute kidney disease: predicting prognosis, exploring interventions, and embracing a multidisciplinary approach
2,939	Biomarkers in pursuit of precision medicine for acute kidney injury: hard to get rid of customs
7,621	Genetic variants of interferon lambda-related genes and chronic kidney disease susceptibility in the Korean population
11,785	How should we treat acute kidney injury caused by renal congestion?
2,750	Personalized nutritional management in the transition from non-dialysis dependent chronic kidney disease to dialysis

Cited By 31	GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Cited By 22	Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
Cited By 18	Uremic pruritus: pathophysiology, clinical presentation, and treatments
Cited By 17	Serum cystatin C to creatinine ratio is associated with sarcopenia in non-dialysis-dependent chronic kidney disease
Cited By 16	The effect of probiotic supplementation on systemic inflammation in dialysis patients

Search